Article metrics

other Versions

Download PDFPDF

A multicenter phase II randomized trial of durvalumab (MEDI-4736) versus physician’s choice chemotherapy in recurrent ovarian clear cell adenocarcinoma (MOCCA)

 

Online download statistics by month:

Online download statistics by month: June 2020 to August 2020

AbstractFullPdf
Jun 202013112344
Jul 202016916148
Aug 202016168
Total316300100